Truffle roots for new biotechs after first close of a planned $240M fund
After striking sales deals on a couple of its medtech plays last year, France’s Truffle Capital has raised the first $102 million of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
